PDF herunterladen
Thorac Cardiovasc Surg Rep 2016; 05(01): 27-29
DOI: 10.1055/s-0036-1583298
Case Report: Cardiac
Georg Thieme Verlag KG Stuttgart · New York

Transcatheter Valve Unable to Cure Patient–Prosthesis Mismatch of Mosaic Bioprosthesis

Daniela Serio
1   Department of Cardiovascular Surgery, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
,
Andreas Zierer
2   Department of Cardiovascular Surgery, Goethe Universitäts Klinik, Frankfurt am Main, Germany
,
Mirko Doss
1   Department of Cardiovascular Surgery, Kerckhoff Klinik GmbH, Bad Nauheim, Germany
,
Anton Moritz
2   Department of Cardiovascular Surgery, Goethe Universitäts Klinik, Frankfurt am Main, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

12. Juli 2015

16. März 2016

Publikationsdatum:
01. Juni 2016 (online)

   Lizenzen und Reprints

Abstract

Transcatheter aortic valve implantation (TAVI) has been recently established as a less invasive alternative to conventional aortic valve replacement (CAVR) in patients presenting with expected high procedural risk. The rapid technologic advances and the recent improvement of clinical outcomes with TAVI have made it possible to treat degenerated bioprosthesis using the valve-in-valve implantation concept (Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116(11, Suppl):I240–I245; Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116(7):755–763). Recently, concerns were raised regarding the appropriate sizing of transcatheter valve prosthesis and its effect on residual stenosis (Klaaborg KE, Egeblad H, Jakobsen CJ, et al. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve. Ann Thorac Surg 2009;87(6):1943–1946; Zedig R, Achouh P, Berrebi A, et al. Valve- in- a- valve implantation: a word of caution. Ann Thorac Surg 2009;87:1943–1946), eventually resulting in a patient–prosthesis mismatch (PPM). We report a case with severe PPM after inserting a 23-mm Sapien (Edwards Lifesciences, Irvine, United States) valve into degenerated 23-mm Medtronic Mosaic prosthesis (Medtronic, Minneapolis, Minnesota, United States).

Keywords

aortic valve and root - surgery - heart valve - transapical - TAVI
 

  • References

  • 1 Walther T, Simon P, Dewey T , et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116 (11, Suppl): I240-I245
    PubMedGoogle Scholar
  • 2 Webb JG, Pasupati S, Humphries K , et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116 (7) 755-763
    CrossrefPubMedGoogle Scholar
  • 3 Klaaborg KE, Egeblad H, Jakobsen CJ , et al. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN Transcatheter Heart Valve. Ann Thorac Surg 2009; 87 (6) 1943-1946
    CrossrefPubMedGoogle Scholar
  • 4 Ferrari E, Marcucci C, Sulzer C, von Segesser LK. Which available transapical transcatheter valve fits into degenerated aortic bioprostheses?. Interact Cardiovasc Thorac Surg 2010; 11 (1) 83-85
    CrossrefPubMedGoogle Scholar
  • 5 Thielmann M, Wendt D, Eggebrecht H , et al. Transcatheter aortic valve implantation in patients with very high risk for conventional aortic valve replacement. Ann Thorac Surg 2009; 88 (5) 1468-1474
    CrossrefPubMedGoogle Scholar
  • 6 Gurvitch R, Cheung A, Ye J , et al. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol 2011; 58 (21) 2196-2209
    CrossrefPubMedGoogle Scholar
  • 7 Shibata T, Inoue K, Ikuta T, Bito Y, Yoshioka Y, Mizoguchi H. Which valve and which size should we use in the valve-on-valve technique for re-do mitral valve surgery?. Interact Cardiovasc Thorac Surg 2009; 8 (2) 206-210
    PubMedGoogle Scholar